Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Goodwill: 2023-2024

Historic Goodwill for Zevra Therapeutics (ZVRA) over the last 2 years, with Dec 2024 value amounting to $4.7 million.

  • Zevra Therapeutics' Goodwill changed negligibly% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $4.7 million for FY2024, which is negligibly% changed negligibly from last year.
  • Zevra Therapeutics' Goodwill amounted to $4.7 million in FY2024, which was down 0.00% from $4.7 million recorded in FY2023.
  • Zevra Therapeutics' Goodwill's 5-year high stood at $4.7 million during FY2023, with a 5-year trough of $4.7 million in FY2023.
  • Over the past 2 years, Zevra Therapeutics' median Goodwill value was $4.7 million (recorded in 2024), while the average stood at $4.7 million.